Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma. (Q53220241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Konstantia E Tasioudi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Stratigoula Sakellariou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Georgia Levidou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Dimitrios Theodorou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Nikolaos V Michalopoulos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Efstratios Patsouris

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Penelope Korkolopoulou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

27 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

Acta Pathologica et Microbiologica Scandinavica

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

639-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

Lapatinib, a dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2, potentiates the antitumor effects of cisplatin on esophageal carcinoma

6 March 2020

cites work

1 reference

Genomic and molecular characterization of esophageal squamous cell carcinoma

21 January 2018

1 reference

Targeting the PI3K-AKT-mTOR signaling network in cancer

21 January 2018

1 reference

Oncogenic PI3K and its role in cancer

21 January 2018

1 reference

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

21 January 2018

1 reference

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.

21 January 2018

1 reference

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

21 January 2018

1 reference

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO

21 January 2018

1 reference

Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.

21 January 2018

1 reference

pERK activation in esophageal carcinomas: clinicopathological associations

21 January 2018

1 reference

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma

21 January 2018

1 reference

Cross‐signaling among phosphinositide‐3 kinase, mitogen‐activated protein kinase and sonic hedgehog pathways exists in esophageal cancer

21 January 2018

1 reference

Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

PIK3CA mutation status in Japanese esophageal squamous cell carcinoma

21 January 2018

1 reference

High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations

21 January 2018

1 reference

Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.

21 January 2018

1 reference

Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma.

21 January 2018

1 reference

Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas

21 January 2018

1 reference

Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma

21 January 2018

1 reference

Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase

21 January 2018

1 reference

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

21 January 2018

1 reference

The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

21 January 2018

1 reference

Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders

21 January 2018

1 reference

AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.

21 January 2018

1 reference

Regulation of Raf-Akt Cross-talk

21 January 2018

1 reference

4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors

21 January 2018

1 reference

ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma

21 January 2018

1 reference

Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas

21 January 2018

1 reference

Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.

21 January 2018

1 reference

Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder

21 January 2018

1 reference

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy

21 January 2018

1 reference

Trends in oesophageal cancer incidence and mortality in Europe

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APM.12398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25912437%20AND%20SRC:MED&resulttype=core&format=json

release_pexsu5rrmvfwjetoullybroyfi

6 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pexsu5rrmvfwjetoullybroyfi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference